|
|
||||||||
Biology of Reproduction, Vol 1, 258-263, Copyright © 1969 by Society for the Study of Reproduction
1 The Rockefeller University, New York, New Fork 10021 It is well known that the decidual transformation of the rat uterus can be inhibited by
the intraluminal administration of antihistaminic drugs. Recent studies on intrauterine
foreign bodies in rats have indicated that a uterine inflammatory reaction can also inhibit
decidualization. It was therefore of interest to determine whether uterine inflammation
might result from the intraluminal administration of antibistaminic drugs in doses sufficient to inhibit decidualization. Four antihistaminic drugs were used. Each was administered at a dose of 1.0 mg per horn to the lumen of one uterine horn in six rats on Day 2
of pregnancy. In all animals this treatment resulted in an inflammatory reaction in the
endometrium on Day 5 of pregnancy. In addition, 1.0 mg of Dibenamine was administered to the lumen of one uterine horn
in six rats and inflammation was again noted in each case. Dibenamine at 1.0 mg per
horn completely prevented decidualization in one horn in five rats, and at 0.5 mg per
horn resulted in an average inhibition of 79% in one horn in six rats. Dibenamine is an
adrenergic blocking agent with very little antihistaminic activity, and it would not be
expected to inhibit decidualization in this dose range if only antihistaminic activity were
involved. These observations suggest that the inhibition of decidualization produced by
intraluminal antihistamines is due to uterine inflammation, rather than to the antihistaminic activity. This interpretation conflicts with the proposal that histamine may be
the physiological inducer of the decidual reaction.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |